首页> 外国专利> Compound 4 - (2S, 3S) - 2-ethyl-3-hydroxy-5-oxoprolidin-1-il - 2 - (trifluoromethyl) benzoate or one of its salts, modulator of androgenes receptor; pharmacological synthesis; and use of the compound to prevent or treat low gonadism, male climate disorders, weakness, anoxia, osteoporosis, Prostatic hypertrophy and amitorofi

Compound 4 - (2S, 3S) - 2-ethyl-3-hydroxy-5-oxoprolidin-1-il - 2 - (trifluoromethyl) benzoate or one of its salts, modulator of androgenes receptor; pharmacological synthesis; and use of the compound to prevent or treat low gonadism, male climate disorders, weakness, anoxia, osteoporosis, Prostatic hypertrophy and amitorofi

机译:化合物4-[((2S,3S)-2-乙基-3-羟基-5-氧代脯氨酸-1-il] -2-(三氟甲基)苯甲酸酯或其盐之一,雄激素受体的调节剂;药理合成化合物预防和治疗性腺功能低下,男性气候异常,虚弱,缺氧,骨质疏松,前列腺肥大和阿米替芬的用途

摘要

Compound 4 - [(2S, 3S) - 2 - ethyl - 3 - hydroxy - 3 - oxopirrolidin - triazin-1-yl] - 2 - (trifluoromethyl) benzonitrile or one of its Salts, Pharmaceutical Composition and its use in hypogonadism,Male Climacteric Disorder, Weakness, wasting disease, prostatic hypertrophy, atrophy, osteoporosis, through Modulation of the androgen receptor.
机译:化合物4-[(2S,3S)-2-乙基-3-羟基-3-氧吡咯烷酮-三嗪-1-基]-2-(三氟甲基)苄腈或其盐之一,药物组合物及其在性腺功能减退症中的用途,男性更年期疾病,虚弱,消瘦疾病,前列腺肥大,萎缩,骨质疏松症,通过调节雄激素受体来实现。

著录项

  • 公开/公告号CL2008002313A1

    专利类型

  • 公开/公告日2009-05-15

    原文格式PDF

  • 申请/专利权人 TAKEDA PHARMACEUTICAL COMPANY LIMITED;

    申请/专利号CL20080002313

  • 发明设计人 ATSUSHI HASUOKA;

    申请日2008-08-06

  • 分类号A61K31/4015;A61P15/12;A61P19/10;A61P5/00;C07D207/273;C07D209/54;

  • 国家 CL

  • 入库时间 2022-08-21 19:28:22

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号